Immunotherapy in Acral and Mucosal Melanoma: Current Status and Future DirectionsLili Mao, Lu Si, Zhonghui Qi et al.|Frontiers in Immunology|2021Cited by 163
MicroRNA-23a-3p Inhibits Mucosal Melanoma Growth and Progression through Targeting Adenylate Cyclase 1 and Attenuating cAMP and MAPK PathwaysMeng Ma, Jun Guo, Tianxiao Xu et al.|Theranostics|2019Cited by 70
Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort studyXue Bai, Keith T. Flaherty, Shaheen Ahmed et al.|EClinicalMedicine|2023Cited by 26